Docoh
Loading...

ALNA Allena Pharmaceuticals

GRANT
Utility
Crystallized oxalate decarboxylase and methods of use
28 Dec 21
Pharmaceutical compositions comprising spray-dried oxalate decarboxylase crystals are disclosed.
Jack Greene, Richard Johnson, Dennis Krushinskie, Bhami Shenoy
Filed: 14 Jan 20
GRANT
Utility
Compositions, methods, and devices for dialysis
3 Aug 21
Compositions of peritoneal dialysis solutions and metabolizing enzymes, and their uses to treat disorders associated with elevated levels of metabolites are disclosed.
Alexey Margolin, Danica Grujic, Stefan Pierzynowski
Filed: 6 Jun 14
GRANT
Utility
Recombinant uricase enzyme
26 Oct 20
Disclosed are recombinant mutant Candida utilis uricase enzymes with improved pancreatin stability and/or activity, compositions containing such uricase enzymes, which can be used, among other things, to treat diseases or disorders associated with an elevated amount of uric acid, including, for example, hyperuricemia, hyperuricosuria, and gout.
Aditi R. Deshpande, Danica Grujic, Sridhar Govindarajan, Mark Welch
Filed: 4 Nov 19
APP
Utility
Recombinant Uricase Enzyme
30 Sep 20
Disclosed are recombinant mutant Candida utilis uricase enzymes with improved pancreatin stability and/or activity, compositions containing such uricase enzymes, which can be used, among other things, to treat diseases or disorders associated with an elevated amount of uric acid, including, for example, hyperuricemia, hyperuricosuria, and gout.
Aditi R. DESHPANDE, Danica GRUJIC, Sridhar GOVINDARAJAN, Mark WELCH
Filed: 5 Jul 18
APP
Utility
Crystallized Oxalate Decarboxylase and Methods of Use
29 Apr 20
Oxalate decarboxylase crystals, including stabilized crystals, such as cross-linked crystals of oxalate decarboxylase, are disclosed.
Bhami C. Shenoy, Teresa G. Cachero, John Shin, Lekai Zhang, Aftab Rashid, Danica Grujic, Reena J. Patel, Margaret Ellen McGrath
Filed: 18 Jun 19
APP
Utility
Crystallized Oxalate Decarboxylase and Methods of Use
29 Apr 20
Pharmaceutical compositions comprising spray-dried oxalate decarboxylase crystals are disclosed.
Jack Greene, Richard Johnson, Dennis Krushinskie, Bhami Shenoy
Filed: 13 Jan 20
APP
Utility
Recombinant Uricase Enzyme
4 Mar 20
Disclosed are recombinant mutant Candida utilis uricase enzymes with improved pancreatin stability and/or activity, compositions containing such uricase enzymes, which can be used, among other things, to treat diseases or disorders associated with an elevated amount of uric acid, including, for example, hyperuricemia, hyperuricosuria, and gout.
Aditi R. Deshpande, Danica Grujic, Sridhar Govindarajan, Mark Welch
Filed: 4 Nov 19
GRANT
Utility
Crystallized oxalate decarboxylase and methods of use
24 Feb 20
Pharmaceutical compositions comprising spray-dried oxalate decarboxylase crystals are disclosed.
Jack Greene, Richard Johnson, Dennis Krushinskie, Bhami Shenoy
Filed: 13 Feb 19
APP
Utility
Crystallized Oxalate Decarboxylase and Methods of Use
22 Jan 20
Pharmaceutical compositions comprising spray-dried oxalate decarboxylase crystals are disclosed.
Jack Greene, Richard Johnson, Dennis Krushinskie, Bhami Shenoy
Filed: 13 Feb 19
  • 1
Patents are sorted by USPTO publication date, most recent first